Back
Akari Therapeutics PLC Vs. Innodata Industry Stock Comparison
Buy
51
AKTX
Akari Therapeutics PLC
Last Price:
$1.39
Seasonality Move:
-7.58%
Buy
63
INOD
Innodata
Last Price:
$43.78
Seasonality Move:
3.52%
Buy
51
Akari Therapeutics PLC (AKTX)
is a Buy
Is Akari Therapeutics PLC a Buy, Sell or Hold?
-
The current Akari Therapeutics PLC [AKTX] share price is $1.31. The Score for AKTX is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
-
AKTX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
AKTX Stock Price Chart
What is Akari Therapeutics PLC's stock price today?
-
The Akari Therapeutics PLC share price today is $1.31The current trend is relatively stagnant and AKTX is experiencing buying pressure, which is a positive indicator for future bullish movement.
AKTX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.11 | Sell |
Relative Strength Index (14 RSI): | 54.46 | Buy |
Chaikin Money Flow: | 40884 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.96 - 1.24) | Buy |
Bollinger Bands (100): | (1.44 - 3.34) | Sell |
INOD Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.48 | Buy |
Relative Strength Index (14 RSI): | 57.39 | Buy |
Chaikin Money Flow: | 1235602 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (37.31 - 44.33) | Buy |
Bollinger Bands (100): | (14.45 - 38.63) | Buy |
AKTX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.08 | Buy |
20-day SMA: | 1.06 | Buy |
50-day SMA: | 1.6 | Sell |
200-day SMA: | 2.38 | Sell |
8-day EMA: | 1.13 | Buy |
20-day EMA: | 1.15 | Buy |
50-day EMA: | 1.55 | Sell |
200-day EMA: | 2.48 | Sell |
INOD Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 42.92 | Buy |
20-day SMA: | 40.73 | Buy |
50-day SMA: | 36.64 | Buy |
200-day SMA: | 19.33 | Buy |
8-day EMA: | 42 | Buy |
20-day EMA: | 40.96 | Buy |
50-day EMA: | 36.31 | Buy |
200-day EMA: | 22.92 | Buy |
Akari Therapeutics PLC Earnings Growth & AKTX Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Innodata Earnings Growth & INOD Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.04 per share, and an increase next year of $0.41 per share.
Akari Therapeutics PLC Technical Analysis
Dec 19 | Dec 20 | Dec 23 | Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
19 | 20 | 23 | 24 | 26 | 27 | 30 | 31 | 02 | 03 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Innodata Technical Analysis
Dec 19 | Dec 20 | Dec 23 | Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
19 | 20 | 23 | 24 | 26 | 27 | 30 | 31 | 02 | 03 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |